Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality

Christina M. Parrinello, Pamela L. Lutsey, Christie M. Ballantyne, Aaron R. Folsom, James S. Pankow, Elizabeth Selvin

Research output: Contribution to journalArticle

Abstract

Background Single measurements of elevated high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of diabetes, cardiovascular disease, and mortality. Large increases or sustained elevations in hs-CRP may be associated with even greater risk of these outcomes. The objective of this study was to characterize the association of 6-year change in hs-CRP with incident diabetes, incident cardiovascular events (heart disease, stroke, and heart failure), and mortality. Methods We included 10,160 ARIC participants with hs-CRP measured at visits 2 (1990-1992) and 4 (1996-1998). Change in hs-CRP was categorized as sustained low/moderate (3 mg/L at visit 2 and 3 mg/L at visit 4), and sustained elevated (>3 mg/L at both visits). Cox proportional hazards models were used to assess the association of 6-year change in hs-CRP with incident diabetes, cardiovascular events, and death during ~15 years after visit 4. Results Compared with persons with sustained low/moderate hs-CRP, those with increased or sustained elevated hs-CRP had an increased risk of incident diabetes (hazard ratios [95% CIs] 1.56 [1.38-1.76] and 1.39 [1.25-1.56], respectively), whereas those with deceased hs-CRP did not. Persons with sustained elevated hs-CRP had an increased risk of coronary heart disease, ischemic stroke, heart failure, and mortality (hazard ratios [95% CIs] 1.51 [1.23-1.85], 1.70 [1.32-2.20], 1.60 [1.35-1.89], and 1.52 [1.37-1.69], respectively) compared with those with sustained low/moderate hs-CRP. Associations for sustained elevated hs-CRP were greater than for those with increased hs-CRP over 6 years. Conclusions Large increases or sustained elevations in hs-CRP over a 6-year period were associated with a subsequent increased risk of diabetes, and persons with sustained elevations in hs-CRP were at the highest risk for cardiovascular disease and mortality. Two measurements of hs-CRP are better than one for characterizing risk, and large increases are particularly prognostic.

Original languageEnglish (US)
Pages (from-to)380-389.e4
JournalAmerican Heart Journal
Volume170
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

C-Reactive Protein
Cardiovascular Diseases
Mortality
Heart Failure
Stroke
Proportional Hazards Models
Coronary Disease
Heart Diseases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. / Parrinello, Christina M.; Lutsey, Pamela L.; Ballantyne, Christie M.; Folsom, Aaron R.; Pankow, James S.; Selvin, Elizabeth.

In: American Heart Journal, Vol. 170, No. 2, 01.08.2015, p. 380-389.e4.

Research output: Contribution to journalArticle

Parrinello, Christina M. ; Lutsey, Pamela L. ; Ballantyne, Christie M. ; Folsom, Aaron R. ; Pankow, James S. ; Selvin, Elizabeth. / Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. In: American Heart Journal. 2015 ; Vol. 170, No. 2. pp. 380-389.e4.
@article{c444544bbf41469d986fac14eebfb8f3,
title = "Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality",
abstract = "Background Single measurements of elevated high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of diabetes, cardiovascular disease, and mortality. Large increases or sustained elevations in hs-CRP may be associated with even greater risk of these outcomes. The objective of this study was to characterize the association of 6-year change in hs-CRP with incident diabetes, incident cardiovascular events (heart disease, stroke, and heart failure), and mortality. Methods We included 10,160 ARIC participants with hs-CRP measured at visits 2 (1990-1992) and 4 (1996-1998). Change in hs-CRP was categorized as sustained low/moderate (3 mg/L at visit 2 and 3 mg/L at visit 4), and sustained elevated (>3 mg/L at both visits). Cox proportional hazards models were used to assess the association of 6-year change in hs-CRP with incident diabetes, cardiovascular events, and death during ~15 years after visit 4. Results Compared with persons with sustained low/moderate hs-CRP, those with increased or sustained elevated hs-CRP had an increased risk of incident diabetes (hazard ratios [95{\%} CIs] 1.56 [1.38-1.76] and 1.39 [1.25-1.56], respectively), whereas those with deceased hs-CRP did not. Persons with sustained elevated hs-CRP had an increased risk of coronary heart disease, ischemic stroke, heart failure, and mortality (hazard ratios [95{\%} CIs] 1.51 [1.23-1.85], 1.70 [1.32-2.20], 1.60 [1.35-1.89], and 1.52 [1.37-1.69], respectively) compared with those with sustained low/moderate hs-CRP. Associations for sustained elevated hs-CRP were greater than for those with increased hs-CRP over 6 years. Conclusions Large increases or sustained elevations in hs-CRP over a 6-year period were associated with a subsequent increased risk of diabetes, and persons with sustained elevations in hs-CRP were at the highest risk for cardiovascular disease and mortality. Two measurements of hs-CRP are better than one for characterizing risk, and large increases are particularly prognostic.",
author = "Parrinello, {Christina M.} and Lutsey, {Pamela L.} and Ballantyne, {Christie M.} and Folsom, {Aaron R.} and Pankow, {James S.} and Elizabeth Selvin",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.ahj.2015.04.017",
language = "English (US)",
volume = "170",
pages = "380--389.e4",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality

AU - Parrinello, Christina M.

AU - Lutsey, Pamela L.

AU - Ballantyne, Christie M.

AU - Folsom, Aaron R.

AU - Pankow, James S.

AU - Selvin, Elizabeth

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background Single measurements of elevated high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of diabetes, cardiovascular disease, and mortality. Large increases or sustained elevations in hs-CRP may be associated with even greater risk of these outcomes. The objective of this study was to characterize the association of 6-year change in hs-CRP with incident diabetes, incident cardiovascular events (heart disease, stroke, and heart failure), and mortality. Methods We included 10,160 ARIC participants with hs-CRP measured at visits 2 (1990-1992) and 4 (1996-1998). Change in hs-CRP was categorized as sustained low/moderate (3 mg/L at visit 2 and 3 mg/L at visit 4), and sustained elevated (>3 mg/L at both visits). Cox proportional hazards models were used to assess the association of 6-year change in hs-CRP with incident diabetes, cardiovascular events, and death during ~15 years after visit 4. Results Compared with persons with sustained low/moderate hs-CRP, those with increased or sustained elevated hs-CRP had an increased risk of incident diabetes (hazard ratios [95% CIs] 1.56 [1.38-1.76] and 1.39 [1.25-1.56], respectively), whereas those with deceased hs-CRP did not. Persons with sustained elevated hs-CRP had an increased risk of coronary heart disease, ischemic stroke, heart failure, and mortality (hazard ratios [95% CIs] 1.51 [1.23-1.85], 1.70 [1.32-2.20], 1.60 [1.35-1.89], and 1.52 [1.37-1.69], respectively) compared with those with sustained low/moderate hs-CRP. Associations for sustained elevated hs-CRP were greater than for those with increased hs-CRP over 6 years. Conclusions Large increases or sustained elevations in hs-CRP over a 6-year period were associated with a subsequent increased risk of diabetes, and persons with sustained elevations in hs-CRP were at the highest risk for cardiovascular disease and mortality. Two measurements of hs-CRP are better than one for characterizing risk, and large increases are particularly prognostic.

AB - Background Single measurements of elevated high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of diabetes, cardiovascular disease, and mortality. Large increases or sustained elevations in hs-CRP may be associated with even greater risk of these outcomes. The objective of this study was to characterize the association of 6-year change in hs-CRP with incident diabetes, incident cardiovascular events (heart disease, stroke, and heart failure), and mortality. Methods We included 10,160 ARIC participants with hs-CRP measured at visits 2 (1990-1992) and 4 (1996-1998). Change in hs-CRP was categorized as sustained low/moderate (3 mg/L at visit 2 and 3 mg/L at visit 4), and sustained elevated (>3 mg/L at both visits). Cox proportional hazards models were used to assess the association of 6-year change in hs-CRP with incident diabetes, cardiovascular events, and death during ~15 years after visit 4. Results Compared with persons with sustained low/moderate hs-CRP, those with increased or sustained elevated hs-CRP had an increased risk of incident diabetes (hazard ratios [95% CIs] 1.56 [1.38-1.76] and 1.39 [1.25-1.56], respectively), whereas those with deceased hs-CRP did not. Persons with sustained elevated hs-CRP had an increased risk of coronary heart disease, ischemic stroke, heart failure, and mortality (hazard ratios [95% CIs] 1.51 [1.23-1.85], 1.70 [1.32-2.20], 1.60 [1.35-1.89], and 1.52 [1.37-1.69], respectively) compared with those with sustained low/moderate hs-CRP. Associations for sustained elevated hs-CRP were greater than for those with increased hs-CRP over 6 years. Conclusions Large increases or sustained elevations in hs-CRP over a 6-year period were associated with a subsequent increased risk of diabetes, and persons with sustained elevations in hs-CRP were at the highest risk for cardiovascular disease and mortality. Two measurements of hs-CRP are better than one for characterizing risk, and large increases are particularly prognostic.

UR - http://www.scopus.com/inward/record.url?scp=84939562013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939562013&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2015.04.017

DO - 10.1016/j.ahj.2015.04.017

M3 - Article

VL - 170

SP - 380-389.e4

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2

ER -